Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

In a powerful act of compassion and community, Starr’s Mill High School organized an early graduation for rising senior ...

A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

As a result of being afflicted with PLS, he is unable to walk and is dependent on a caregiver for help with his daily needs.

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with ...

Neurizon Therapeutics has announced it has received positive feedback from the US Food and Drug Administration (FDA) on its ...

JJ Potrikus, vice president of the New York Collegiate Baseball League, joined Bridge Street for details this morning along ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.